company background image
600513 logo

Jiangsu Lianhuan Pharmaceutical SHSE:600513 Stock Report

Last Price

CN¥9.18

Market Cap

CN¥2.6b

7D

-1.6%

1Y

-16.8%

Updated

24 Mar, 2024

Data

Company Financials

Jiangsu Lianhuan Pharmaceutical Co., Ltd.

SHSE:600513 Stock Report

Market Cap: CN¥2.6b

600513 Stock Overview

Jiangsu Lianhuan Pharmaceutical Co., Ltd.

600513 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends3/6

Jiangsu Lianhuan Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Jiangsu Lianhuan Pharmaceutical
Historical stock prices
Current Share PriceCN¥9.18
52 Week HighCN¥14.40
52 Week LowCN¥6.71
Beta0.41
1 Month Change5.28%
3 Month Change-16.16%
1 Year Change-16.85%
3 Year Change7.37%
5 Year Change20.31%
Change since IPO186.06%

Recent News & Updates

We Think That There Are More Issues For Jiangsu Lianhuan Pharmaceutical (SHSE:600513) Than Just Sluggish Earnings

Mar 12
We Think That There Are More Issues For Jiangsu Lianhuan Pharmaceutical (SHSE:600513) Than Just Sluggish Earnings

Recent updates

We Think That There Are More Issues For Jiangsu Lianhuan Pharmaceutical (SHSE:600513) Than Just Sluggish Earnings

Mar 12
We Think That There Are More Issues For Jiangsu Lianhuan Pharmaceutical (SHSE:600513) Than Just Sluggish Earnings

Shareholder Returns

600513CN PharmaceuticalsCN Market
7D-1.6%-1.6%-0.03%
1Y-16.8%-8.6%-14.2%

Return vs Industry: 600513 underperformed the CN Pharmaceuticals industry which returned -8.6% over the past year.

Return vs Market: 600513 underperformed the CN Market which returned -14.2% over the past year.

Price Volatility

Is 600513's price volatile compared to industry and market?
600513 volatility
600513 Average Weekly Movement7.5%
Pharmaceuticals Industry Average Movement6.9%
Market Average Movement8.1%
10% most volatile stocks in CN Market11.3%
10% least volatile stocks in CN Market5.1%

Stable Share Price: 600513 has not had significant price volatility in the past 3 months.

Volatility Over Time: 600513's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19991,296Ben Niuhttps://www.lhpharma.com

Jiangsu Lianhuan Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals, preparations, and API products in China. The company offers clopidogrel bisulfate tablets used to prevent atherothrombotic events; azithromycin tablets for the treatment of mild to moderate infections caused by susceptible strains of designated microorganisms; milrinone injection for short-term intravenous therapy in patients with acute compensated heart failure; and dapoxetine hydrochloride tablets for the treatment of premature ejaculation in men, as well as epulet, ebastine, felodipine, and terfenadine tablets, drotaverine hydrochloride injection, and danazol suppository. It also offers preparation products, which covers urinary system, antihistamines, cardiovascular drugs, steroid hormones, and antibiotics.

Jiangsu Lianhuan Pharmaceutical Co., Ltd. Fundamentals Summary

How do Jiangsu Lianhuan Pharmaceutical's earnings and revenue compare to its market cap?
600513 fundamental statistics
Market capCN¥2.62b
Earnings (TTM)CN¥135.01m
Revenue (TTM)CN¥2.17b

19.4x

P/E Ratio

1.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600513 income statement (TTM)
RevenueCN¥2.17b
Cost of RevenueCN¥1.13b
Gross ProfitCN¥1.04b
Other ExpensesCN¥908.99m
EarningsCN¥135.01m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.47
Gross Margin48.02%
Net Profit Margin6.21%
Debt/Equity Ratio46.2%

How did 600513 perform over the long term?

See historical performance and comparison

Dividends

1.6%

Current Dividend Yield

32%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.